New Catalysts Could Send This $3 Medical Device Stock to $9

- Cardiovascular remote monitoring solutions have been big successes for companies like iRhythym (IRTC) and Biotelemetry (BEAT); the latter has climbed from $2 to $48!

- New entrant Biotricity (BTCY) is jumping into the same market with a potentially superior product and under-appreciated market valuation. They received FDA clearance at the end of 2017, and their upcoming sales figures, even conservatively, could send this $3 stock to $9 or more in due time.

- BTCY expects to be prepared with two more products in the next 6-9 months, and they could all be on the market by the end of 2019.

With their latest investor update, Biotricity Inc. (BTCY) just dropped a major hint that most investors have been missing so far... key product updates are coming later this year.

Biotricity is a medical device company that ...View the full post at: New Catalysts Could Send This $3 Medical Device Stock to $9 ...

Related Articles:

Payment Data Systems (PYDS) a Strong Buy at Current Price Point

Is This The Oil Tech Breakthrough Of The Decade?

Permex Petroleum Completes Acquisition of the ODC San Andres and Taylor Properties in Gaines County Texas

A Savvy Biotech Investor Is Betting Up To $25 Million Dollars On This $8 Stock Returning 250%... Or More?

Sign Up

Get the InvestingChannel
Free e-Letter Today

Learn More

Independent market opinion, analysis and ideas - delivered every business day

Premium market opinions, analysis, and ideas - delivered every business day

Editor's Picks